This clinical trial will determine if AL-46383A ophthalmic solution is an effective treatment for adenoviral conjunctivitis.
Study Type: Interventional
Age/Gender Requirements: 6 years+ (male/female)
Sponsor: Alcon Research
Purpose: To determine the safety and efficacy of AL-46383A Ophthalmic Solution in the treatment of adenoviral conjunctivitis.
Click here to access this third-party resource.